The next-generation ultrasound system reportedly offers enhanced images through graphic-based beamforming technology, a variety of artificial intelligence (AI)-powered tools and reduced exam times.
Expanding upon its women’s health portfolio, GE Healthcare has launched the Voluson Expert 22 ultrasound system.
Providing enhanced imaging capabilities through the device’s Lyric Architecture, the Voluson Expert 22 ultrasound system accommodates a variety of body sizes, according to the company. Combining new levels of penetration and frame rates, GE Healthcare said the new system provides enhanced anatomical detail on a 23.8 inch high-definition ultrasound display with increased contrast and spatial resolution.
“The Voluson Expert 22 is a masterpiece of engineering with exceptional 2D images from thin to difficult scanning patients. This machine also has the outstanding ergonomics and is the most customizable system ever produced, It is one of the best ultrasound machines I have ever used,” noted Rabih Chaoui, M.D., the managing director at the Center for Prenatal Diagnosis and Human Genetics in Berlin, Germany.
In addition to a user interface that allows personalized preferences and automated probe presets, the Voluson Expert 22 offers a variety of artificial intelligence (AI)-enabled tools. GE Healthcare noted that SonoLyst provides annotations and measurements that improve the efficiency of viewing fetal anatomy by up to 65 percent. Facilitating consistent measurements and enhanced alignment of 3D views of the fetal brain, the SonoCNS feature reportedly reduces exam time by 81 percent, according to the company.
“By using AI, we are pushing limits and enhancing diagnostic capabilities. At the same time, the functionality makes exams easier. The AI built into this machine is so far advanced compared to what we’ve seen before, and it’s only a hint. It’s our responsibility to push it even further by using it, challenging it, and showing it makes a difference,” said Lawrence Platt, M.D., an obstetrician-gynecologist at the Center for Fetal Medicine in Los Angeles.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.
New Literature Review Finds ChatGPT Effective in Radiology in 84 Percent of Studies
April 29th 2024While noting a variety of pitfalls with the chatbot ranging from hallucinations to improper citations, the review authors found the use of ChatGPT in radiology demonstrated “high performance” in 37 out of 44 studies.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.
New Literature Review Finds ChatGPT Effective in Radiology in 84 Percent of Studies
April 29th 2024While noting a variety of pitfalls with the chatbot ranging from hallucinations to improper citations, the review authors found the use of ChatGPT in radiology demonstrated “high performance” in 37 out of 44 studies.
2 Commerce Drive
Cranbury, NJ 08512